New, Alpharmaxim

New research by Alpharmaxim applies behavioural science to identify and understand prescribing choices in neurogenerative diseases - and highlights the need to optimise them

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Alpharmaxim United Kingdom England United Arab Emirates United States of America Saudi Arabia Qatar Bahrain Kuwait Iraq Oman

View original content:https://www.prnewswire.co.uk/news-releases/new-research-by-alpharmaxim-applies-behavioural-science-to-identify-and-understand-prescribing-choices-in-neurogenerative-diseases--and-highlights-the-need-to-optimise-them-302496819.html

en | CA7609751028 | NEW | boerse | 67971671 |